Rigshospitalet, Denmark: Coronary Artery Disease trials

The registry lists 31 Coronary Artery Disease studies with Rigshospitalet, Denmark as lead sponsor. 9 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 4Phase 3 2Phase 4 1No phase 23(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• CABGpreHAB - a Feasibility Study ProtocolRecruitingNCT07035171Not applicable
• Coronary Computed Tomography Versus Invasive Angiography for Non-ST Elevation Acute Coronary SyndromeRecruitingNCT06101862Not applicable
• Clinical Implementation of a Novel Decision Support Tool in Patients With Ischemic Heart DiseaseRecruitingNCT06033014Not applicable
• The DANE-HEART Trial - Computed Tomography Coronary Angiography for Primary PreventionEnrolling by invitationNCT05677386Not applicable
• Dexamethasone, Olanzapine, Hemodynamics, and Ventilation in Cardiac SurgeryRecruitingNCT05635227Not applicable
• The HYCORE1 Trial: Hybrid Revascularization Versus Coronary Artery Bypass GraftingNot yet recruitingNCT05504031Not applicable
• CT Stress Myocardial Perfusion, Fractional Flow Reserve and Angiography in Patients With Stable Chest Pain SyndromesRecruitingNCT04709900Not applicable
• A Danish ICD-study in Patients with Coronary Artery Disease Resuscitated from Ventricular FibrillationRecruitingNCT04576130Not applicable
• 68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Angiogenesis in Ischemic Heart DiseaseNot yet recruitingNCT03505346Phase 2
• 'MInimalist' or 'MOre Complete' Strategies for Revascularization in OctogenariansTerminatedNCT04252703Not applicable
• In Vivo Tracking of USPIO Labeled MSC in the HeartCompletedNCT03651791Phase 1
• Culprit Lesions in NSTEMI With Multi Vessel Disease (NSTEMI-CULPRIT)Status unknownNCT03479593
• Characterization of Epicardial and Pericardial Adipose Tissue in Coronary Artery DiseaseCompletedNCT02965625
• Exploration of Cerebral Pathophysiology During and After CABG Using CPBCompletedNCT02941380
• SheppHeartCABG - Phase One Rehabilitation After Coronary Artery Bypass GraftingCompletedNCT02290262Not applicable
• Very Early veRsus Deferred Invasive Evaluation Using Computerized Tomography in Patients With Acute Coronary SyndromesActive, not recruitingNCT02061891Not applicable
• The CardioPAT Project: A Randomized TrialTerminatedNCT02058134Not applicable
• CArdiac cT in the Treatment of Acute CHest Pain 2 - Myocardial CT PerfusionCompletedNCT02014311Not applicable
• Validation of Coronary Calcium Subtraction to Improve Diagnostic Accuracy of Coronary CT AngiographyCompletedNCT02011061
• Trial of Rehabilitation in Phase 1 After Coronary Artery Bypass GraftingCompletedNCT01941355Not applicable
• Neurological Complications Comparing Endoscopically vs. Open Harvest of the Radial ArteryCompletedNCT01848886Not applicable
• MesenchYmal STROMAL CELL Therapy in Patients With Chronic Myocardial Ischemia (MyStromalCell Trial)CompletedNCT01449032Phase 2
• Time to Thrombocytic Inhibition After Supine and Upright Ingestion of EfientCompletedNCT01365741Not applicable
• Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial IschemiaCompletedNCT00260338Phase 1/2
• Stenting With or Without Coating Compared With Angioplasty in Non-benestent DiseaseStatus unknownNCT00192881Not applicable
• Drug Elution and Distal Protection During Percutaneous Coronary Intervention in ST Elevation Myocardial InfarctionStatus unknownNCT00192868Not applicable
• Copenhagen Arterial Revascularization Randomized Patency and Outcome TrialStatus unknownNCT00159991Phase 3
• Cleansing of Suction Blood in Cardiac Surgery for Reduced Inflammatory ResponseTerminatedNCT00159926Phase 3
• Sirolimus Eluting Stents in Complex Coronary Lesions (SCANDSTENT)CompletedNCT00151658Not applicable
• DANish Multicenter STENT TrialCompletedNCT00139802Phase 4
• The Effect of Mobilized Stem Cell by G-CSF and VEGF Gene Therapy in Patients With Stable Severe Angina PectorisCompletedNCT00135850Phase 1/2